{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:30:22Z","timestamp":1794591022622,"version":"4.9.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ymgme.2023.107583","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T18:45:41Z","timestamp":1681584341000},"page":"107583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Phenylketonuria and the brain"],"prefix":"10.1016","volume":"139","author":[{"given":"Valentina","family":"Rovelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2023.107583_bb0005","series-title":"Clinical Paediatric Dietetics - Editeb by Vanessa Shaw","first-page":"514","article-title":"Disorders of amino acid metabolism, organic acidaemiaes and urea cycle disorders - Phenylketonuria","author":"MacDonald","year":"2020"},{"key":"10.1016\/j.ymgme.2023.107583_bb0010","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.ymgme.2009.09.014","article-title":"Disruption of prefrontal function and connectivity in individuals with phenylketonuria\u2606","volume":"99","author":"Christ","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10545-008-0946-2","article-title":"Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?","volume":"32","author":"van Spronsen","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107583_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101916","article-title":"White and gray matter brain development in children and young adults with phenylketonuria","volume":"23","author":"Hawks","year":"2019","journal-title":"NeuroImage Clin."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107583_bb0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1037\/neu0000336","article-title":"The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: effects across tasks and developmental stages","volume":"31","author":"Romani","year":"2017","journal-title":"Neuropsychology."},{"issue":"6","key":"10.1016\/j.ymgme.2023.107583_bb0030","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.numecd.2020.02.003","article-title":"Maternal PKU: defining phenylalanine tolerance and its variation during pregnancy, according to genetic background","volume":"30","author":"Caletti","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2023.107583_bb0035","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0022-3476(96)70328-1","article-title":"Maternal phenylketonuria: magnetic resonance imaging of the brain in offspring","volume":"128","author":"Levy","year":"1996","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107583_bb0040","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ymgme.2009.10.005","article-title":"White matter pathology in phenylketonuria\u2606","volume":"99","author":"Anderson","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2023.107583_bb0045","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1007\/PL00014371","article-title":"The neuropathology of phenylketonuria: human and animal studies","volume":"159","author":"Huttenlocher","year":"2000","journal-title":"Eur. J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/brain\/awh354","article-title":"Long-term changes in glutamatergic synaptic transmission in phenylketonuria","volume":"128","author":"Glushakov","year":"2004","journal-title":"Brain."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107583_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1440-1754.1991.tb00384.x","article-title":"The natural history of untreated phenylketonuria over 20 years","volume":"27","author":"Pitt","year":"1991","journal-title":"J. Paediatr. Child Health"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13023-018-0893-4","article-title":"A systematic review of cognitive functioning in early treated adults with phenylketonuria","volume":"13","author":"Hofman","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2023.107583_bb0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13023-019-1225-z","article-title":"Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels","volume":"14","author":"Romani","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1399-0004.2007.00816.x","article-title":"Executive functioning in children and adolescents with phenylketonuria","volume":"72","author":"VanZutphen","year":"2007","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ymgme.2014.03.005","volume":"112","author":"Greene","year":"2014","journal-title":"Molecular Genetics and Metabolism"},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ymgme.2014.02.013","article-title":"Phenylketonuria Scientific Review Conference: State of the science and future research needs","volume":"112","author":"Camp","year":"2014","journal-title":"Molecular Genetics and Metabolism"},{"issue":"8","key":"10.1016\/j.ymgme.2023.107583_bb0085","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/GIM.0b013e3182141b48","article-title":"Phenylalanine hydroxylase deficiency","volume":"13","author":"Mitchell","year":"2011","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","article-title":"The complete European guidelines on phenylketonuria: diagnosis and treatment","volume":"12","author":"van Wegberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2023.107583_bb0095","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/1467-8624.00370","article-title":"Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria","volume":"72","author":"Luciana","year":"2001","journal-title":"Child Dev."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107583_bb0100","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s11011-018-0267-6","article-title":"The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients","volume":"33","author":"Bartus","year":"2018","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/87565640903325725","article-title":"A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of \u201csafe\u201d levels","volume":"35","author":"Sharman","year":"2010","journal-title":"Dev. Neuropsychol."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085945","article-title":"Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality?","volume":"9","author":"Okusaga","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ymgme.2023.107583_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pedn.2006.08.002","article-title":"Maternal phenylketonuria syndrome and case management implications","volume":"22","author":"Gambol","year":"2007","journal-title":"J. Pediatr. Nurs."},{"issue":"8565","key":"10.1016\/j.ymgme.2023.107583_bb0125","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0140-6736(87)91418-8","article-title":"Timing of strict diet in relation to fetal damage in maternal phenylketonuria. An international collaborative study by the MRC\/DHSS phenylketonuria register","volume":"2","author":"Drogari","year":"1987","journal-title":"Lancet Lond. Engl."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107583_bb0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/(SICI)1096-9926(199603)53:3<176::AID-TERA5>3.0.CO;2-2","article-title":"Maternal phenylketonuria: a metabolic teratogen","volume":"53","author":"Levy","year":"1996","journal-title":"Teratology."},{"issue":"1\u20133","key":"10.1016\/j.ymgme.2023.107583_bb0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0378-4274(01)00501-X","article-title":"Developmental neurotoxicity: do similar phenotypes indicate a common mode of action? A comparison of fetal alcohol syndrome, toluene embryopathy and maternal phenylketonuria","volume":"127","author":"Costa","year":"2002","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1096-8628(19970303)69:1<89::AID-AJMG17>3.0.CO;2-K","article-title":"Maternal phenylketonuria collaborative study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelae","volume":"69","author":"Rouse","year":"1997","journal-title":"Am. J. Med. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jpeds.2003.10.062","article-title":"Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancy","volume":"144","author":"Rouse","year":"2004","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107583_bb0150","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1203\/00006450-200105000-00005","article-title":"Congenital heart disease in maternal phenylketonuria: report from the maternal PKU collaborative study","volume":"49","author":"Levy","year":"2001","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0155","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3945\/ajcn.110.009456","article-title":"Maternal phenylketonuria and hyperphenylalaninemia in pregnancy: pregnancy complications and neonatal sequelae in untreated and treated pregnancies","volume":"95","author":"Prick","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/1096-8628(20001113)95:2<187::AID-AJMG20>3.0.CO;2-G","article-title":"Lobar holoprosencephaly in an infant born to a mother with classic phenylketonuria","volume":"95","author":"Keller","year":"2000","journal-title":"Am. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107583_bb0165","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1469-8749.2008.02028.x","article-title":"Neuropathology of a 4-month-old infant born to a woman with phenylketonuria","volume":"50","author":"Koch","year":"2008","journal-title":"Dev. Med. Child Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(24)38901-3","article-title":"Effect of phenylalanine and its metabolites on the proliferation and viability of neuronal and Astroglial cells: possible relevance in maternal phenylketonuria","volume":"295","author":"Oberdoerster","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.ymgme.2023.107583_bb0175","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ana.410070609","article-title":"Neuropathology of phenylacetate poisoning in rats: an experimental model of phenylketonuria","volume":"7","author":"Wen","year":"1980","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107583_bb0180","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/tera.1420420513","article-title":"Phenylalanine and its metabolites induce embryopathies in mouse embryos in culture","volume":"42","author":"Denno","year":"1990","journal-title":"Teratology."},{"issue":"9","key":"10.1016\/j.ymgme.2023.107583_bb0185","first-page":"3000","article-title":"The neonatal connectome during preterm brain development","volume":"25","author":"van den Heuvel","year":"2015","journal-title":"Cereb. Cortex N. Y. N 1991"},{"issue":"6","key":"10.1016\/j.ymgme.2023.107583_bb0190","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.neubiorev.2006.06.001","article-title":"Brain development in children and adolescents: insights from anatomical magnetic resonance imaging","volume":"30","author":"Lenroot","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/npp.2009.115","article-title":"Normal development of brain circuits","volume":"35","author":"Tau","year":"2010","journal-title":"Neuropsychopharmacology."},{"issue":"10","key":"10.1016\/j.ymgme.2023.107583_bb0200","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/adc.48.10.757","article-title":"Quantitative growth and development of human brain","volume":"48","author":"Dobbing","year":"1973","journal-title":"Arch. Dis. Child."},{"issue":"11","key":"10.1016\/j.ymgme.2023.107583_bb0205","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00213-016-4259-0","article-title":"Acute phenylalanine\/tyrosine depletion of phasic dopamine in the rat brain","volume":"233","author":"Shnitko","year":"2016","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1016\/j.ymgme.2023.107583_bb0210","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1162\/jocn_a_00464","article-title":"Effects of acute dopamine precusor depletion on immediate reward selection bias and working memory depend on catechol-O-methyltransferase genotype","volume":"25","author":"Kelm","year":"2013","journal-title":"J. Cogn. Neurosci."},{"key":"10.1016\/j.ymgme.2023.107583_bb0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pbb.2015.01.014","article-title":"Age moderates the effect of acute dopamine depletion on passive avoidance learning","volume":"131","author":"Kelm","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0220","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0893-133X(99)00086-X","article-title":"Effects on mood of acute phenylalanine\/tyrosine depletion in healthy women","volume":"22","author":"Leyton","year":"2000","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.ymgme.2023.107583_bb0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.brainres.2007.10.079","article-title":"Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels","volume":"1190","author":"Bongiovanni","year":"2008","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107583_bb0230","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/026988119901300408","article-title":"Comparison of the effects of alpha-methyl-p-tyrosine and a tyrosine-free amino acid load on extracellular noradrenaline in the rat hippocampus in vivo","volume":"13","author":"McTavish","year":"1999","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107583_bb0235","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.spen.2016.11.007","article-title":"Impaired neurotransmission in early-treated phenylketonuria patients","volume":"23","author":"Gonz\u00e1lez","year":"2016","journal-title":"Semin. Pediatr. Neurol."},{"issue":"20","key":"10.1016\/j.ymgme.2023.107583_bb0240","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1073\/pnas.97.20.11014","article-title":"Cerebral protein synthesis in a genetic mouse model of phenylketonuria","volume":"97","author":"Smith","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2023.107583_bb0245","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1750-1172-8-133","article-title":"Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis","volume":"8","author":"de Groot","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107583_bb0250","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10545-006-0285-0","article-title":"LAT1 gene variants--potential factors influencing the clinical course of phenylketonuria","volume":"29","author":"Bik-Multanowski","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2023.107583_bb0255","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.ymgme.2005.07.031","article-title":"Inter-individual variation in brain phenylalanine concentration in patients with PKU is not caused by genetic variation in the 4F2hc\/LAT1 complex","volume":"86","author":"M\u00f8ller","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107583_bb0260","article-title":"The rs113883650 variant of SLC7A5 (LAT1) gene may alter brain phenylalanine content in PKU","volume":"27","author":"Bik-Multanowski","year":"2021","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2023.107583_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.564809","article-title":"Review of the correlation of LAT1 with diseases: mechanism and treatment","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Chem."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107583_bb0270","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1471-4159.2003.01887.x","article-title":"Relationship between myelin production and dopamine synthesis in the PKU mouse brain","volume":"86","author":"Joseph","year":"2003","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107583_bb0275","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-4547(20000901)61:5<549::AID-JNR10>3.0.CO;2-0","article-title":"Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse?","volume":"61","author":"Shefer","year":"2000","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0280","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/exnr.1993.1206","article-title":"Retarded development of neurons and oligodendroglia in rat forebrain produced by hyperphenylalaninemia results in permanent deficits in myelin despite long recovery periods","volume":"124","author":"Reynolds","year":"1993","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0285","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10545-006-0399-4","article-title":"The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study","volume":"30","author":"Leuzzi","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0290","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0006-8993(75)90637-X","article-title":"Change in a myelin-associated glycoprotein in rat brain during development: metabolic aspects","volume":"86","author":"Matthieu","year":"1975","journal-title":"Brain Res."},{"issue":"3\u20134","key":"10.1016\/j.ymgme.2023.107583_bb0295","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/00207458308986575","article-title":"Effect of experimental hyperphenylalaninemia on myelin metabolism at later stages of brain development","volume":"20","author":"Taylor","year":"1983","journal-title":"Int. J. Neurosci."},{"issue":"7","key":"10.1016\/j.ymgme.2023.107583_bb0300","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00005072-199607000-00005","article-title":"Evidence for central nervous system glial cell plasticity in phenylketonuria","volume":"55","author":"Dyer","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymgme.2023.107583_bb0305","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fpsyt.2019.00561","article-title":"Psychiatric and cognitive aspects of phenylketonuria: the limitations of diet and promise of new treatments","volume":"10","author":"Ashe","year":"2019","journal-title":"Front. Psychiatr."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0310","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0378-3782(83)90072-5","article-title":"Histological maturation of the neocortex in phenylketonuric rats","volume":"8","author":"Cordero","year":"1983","journal-title":"Early Hum. Dev."},{"issue":"4 Part 1","key":"10.1016\/j.ymgme.2023.107583_bb0315","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1203\/01.pdr.0000203091.45988.8d","article-title":"Phenylalanine reduces synaptic density in mixed cortical cultures from mice","volume":"59","author":"H\u00f6rster","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2023.107583_bb0320","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.expneurol.2016.04.013","article-title":"Phenylketonuria: direct and indirect effects of phenylalanine","volume":"281","author":"Schlegel","year":"2016","journal-title":"Exp. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2023.107583_bb0325","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.ymgme.2005.06.014","article-title":"Impaired glutamatergic synaptic transmission in the PKU brain","volume":"86","author":"Martynyuk","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107583_bb0330","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clinbiochem.2003.10.017","article-title":"A longitudinal study of antioxidant status in phenylketonuric patients","volume":"37","author":"Artuch","year":"2004","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2023.107583_bb0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0065-2571(70)90006-3","article-title":"Regulation of human and rat brain metabolism: inhibitory action of phenylalanine and phenylpyruvate on glycolysis, protein, lipid, DNA, and RNA metabolism","volume":"8","author":"Weber","year":"1970","journal-title":"Adv. Enzym. Regul."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0340","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1203\/00006450-199607000-00004","article-title":"Cerebral glucose metabolism is decreased in white matter changes in patients with phenylketonuria","volume":"40","author":"Hasselbalch","year":"1996","journal-title":"Pediatr. Res."},{"issue":"4076","key":"10.1016\/j.ymgme.2023.107583_bb0345","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.179.4076.904","article-title":"Phenylketonuria: phenylalanine inhibits brain pyruvate kinase in vivo","volume":"179","author":"Miller","year":"1973","journal-title":"Science."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107583_bb0350","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1073\/pnas.63.4.1365","article-title":"Inhibition of human brain pyruvate kinase and hexokinase by phenylalanine and phenylpyruvate: possible relevance to phenylketonuric brain damage","volume":"63","author":"Weber","year":"1969","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2023.107583_bb0355","first-page":"16","article-title":"Calcium homeostasis and calcium-regulating hormones in young children with phenylketonuria","volume":"3","author":"Bushueva","year":"1993","journal-title":"Vopr. Pitan."},{"issue":"8","key":"10.1016\/j.ymgme.2023.107583_bb0360","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s11064-007-9303-3","article-title":"Effects of phenylalanine and its metabolites on cytoplasmic free calcium in cortical neurons","volume":"32","author":"Yu","year":"2007","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0365","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11011-011-9271-9","article-title":"Pyruvate and creatine prevent oxidative stress and behavioral alterations caused by phenylalanine administration into hippocampus of rats","volume":"27","author":"Berti","year":"2012","journal-title":"Metab. Brain Dis."},{"issue":"8","key":"10.1016\/j.ymgme.2023.107583_bb0370","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s11064-014-1353-8","article-title":"Co-administration of creatine plus pyruvate prevents the effects of phenylalanine administration to female rats during pregnancy and lactation on enzymes activity of energy metabolism in cerebral cortex and Hippocampus of the offspring","volume":"39","author":"Bortoluzzi","year":"2014","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0375","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1542\/peds.20.2.290","article-title":"The variability in manifestations of untreated patients with phenylketonuria (phenylpyruvic aciduria)","volume":"20","author":"Paine","year":"1957","journal-title":"Pediatrics."},{"issue":"6","key":"10.1016\/j.ymgme.2023.107583_bb0380","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00019052-199812000-00012","article-title":"Neurological aspects of adult phenylketonuria","volume":"11","author":"Pietz","year":"1998","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ymgme.2023.107583_bb0385","first-page":"62","article-title":"Peculiarities of epileptic syndrome in children with metabolic disorders of nervous system","volume":"128","author":"Pulariani","year":"2005","journal-title":"Georgian Med. News"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2023.107583_bb0390","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","article-title":"Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis","volume":"92","author":"Waisbren","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107583_bb0395","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ajcn\/5.5.543","article-title":"Further observations on the effect of phenylalanine-restricted diet on patients with phenylketonuria","volume":"5","author":"Armstrong","year":"1957","journal-title":"Am. J. Clin. Nutr."},{"issue":"7","key":"10.1016\/j.ymgme.2023.107583_bb0400","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0387-7604(01)00260-1","article-title":"Clinical analysis of west syndrome associated with phenylketonuria","volume":"23","author":"Zhou","year":"2001","journal-title":"Brain Dev."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0405","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00692698","article-title":"Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria","volume":"58","author":"Bauman","year":"1982","journal-title":"Acta Neuropathol. (Berl.)"},{"issue":"5","key":"10.1016\/j.ymgme.2023.107583_bb0410","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/adc.65.5.472","article-title":"Intelligence and quality of dietary treatment in phenylketonuria","volume":"65","author":"Smith","year":"1990","journal-title":"Arch. Dis. Child."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107583_bb0415","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/adc.66.3.311","article-title":"Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria","volume":"66","author":"Smith","year":"1991","journal-title":"Arch. Dis. Child."},{"issue":"6","key":"10.1016\/j.ymgme.2023.107583_bb0420","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1021205713674","article-title":"Short-term dietary interventions in children and adolescents with treated phenylketonuria: effects on neuropsychological outcome of a well-controlled population","volume":"25","author":"Huijbregts","year":"2002","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2023.107583_bb0425","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1023\/A:1005664231017","article-title":"Behavioural and emotional problems in early-treated adolescents with phenylketonuria in comparison with diabetic patients and healthy controls","volume":"23","author":"Weglage","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.03.002","article-title":"Neuropsychiatric comorbidities in adults with phenylketonuria: a retrospective cohort study","volume":"121","author":"Bilder","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107583_bb0435","doi-asserted-by":"crossref","DOI":"10.2307\/1166208","article-title":"Prefrontal cortex cognitive deficits in children treated early and continuously for PKU","volume":"62","author":"Diamond","year":"1997","journal-title":"Monogr. Soc. Res. Child Dev."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0440","first-page":"93","article-title":"Attention deficit disorder with hyperactivity symptoms in early-treated phenylketonuria patients","volume":"14","author":"Beckhauser","year":"2020","journal-title":"Iran J. Child. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107583_bb0445","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ajmg.b.30862","article-title":"Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples","volume":"150B","author":"Talkowski","year":"2009","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2023.107583_bb0450","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0006-3223(02)01528-7","article-title":"Phenylalanine hydroxylase gene in psychiatric patients: screening and functional assay of mutations","volume":"53","author":"Richardson","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ymgme.2023.107583_bb0455","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fneur.2017.00167","article-title":"Sleep disturbances in phenylketonuria: an explorative study in men and mice","volume":"8","author":"Bruinenberg","year":"2017","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0460","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archneur.1981.00510020080013","article-title":"EEG in phenylketonuria. Attempt to establish clinical importance of EEG changes","volume":"38","author":"Gross","year":"1981","journal-title":"Arch. Neurol."},{"issue":"9","key":"10.1016\/j.ymgme.2023.107583_bb0465","first-page":"802","article-title":"EEG pattern in phenylketonuria under early initiated dietary treatment","volume":"135","author":"Blaskovics","year":"1981","journal-title":"Am. J. Dis. Child. 1960"},{"issue":"5","key":"10.1016\/j.ymgme.2023.107583_bb0470","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejpn.2019.08.005","article-title":"Prevalence of sleep disorders in early-treated phenylketonuric children and adolescents. Correlation with dopamine and serotonin status","volume":"23","author":"Gassi\u00f3","year":"2019","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0475","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-3476(95)70303-9","article-title":"Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change","volume":"127","author":"Cleary","year":"1995","journal-title":"J. Pediatr."},{"issue":"11","key":"10.1016\/j.ymgme.2023.107583_bb0480","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/00004647-199811000-00004","article-title":"Blood\u2014brain barrier phenylalanine transport and individual vulnerability in phenylketonuria","volume":"18","author":"M\u00f6ller","year":"1998","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107583_bb0485","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-2007-979753","article-title":"In-vivo NMR spectroscopy in patients with phenylketonuria: changes of cerebral phenylalanine levels under dietary treatment","volume":"26","author":"M\u00f6ller","year":"1995","journal-title":"Neuropediatrics."},{"issue":"Pt 4","key":"10.1016\/j.ymgme.2023.107583_bb0490","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/brain\/116.4.811","article-title":"Brain MRI changes in phenylketonuria. Associations with dietary status","volume":"116","author":"Thompson","year":"1993","journal-title":"Brain J. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107583_bb0495","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00711747","article-title":"Improvements in behaviour and physical manifestations in previously untreated adults with phenylketonuria using a phenylalanine-restricted diet: a national survey","volume":"18","author":"Yannicelli","year":"1995","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Pt 1","key":"10.1016\/j.ymgme.2023.107583_bb0500","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2788.2000.00260.x","article-title":"An investigation into diet treatment for adults with previously untreated phenylketonuria and severe intellectual disability","volume":"44","author":"Fitzgerald","year":"2000","journal-title":"J. Intellect Disabil. Res. JIDR"},{"issue":"Pt 1","key":"10.1016\/j.ymgme.2023.107583_bb0505","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2788.1999.43120176.x","article-title":"Economic impact of feeding a phenylalanine-restricted diet to adults with previously untreated phenylketonuria","volume":"43","author":"Brown","year":"1999","journal-title":"J. Intellect Disabil. Res. JIDR"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107583_bb0510","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13023-020-01379-8","article-title":"Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies","volume":"15","author":"On behalf of the International Working Group on Neurotransmitter related Disorders (iNTD)","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"Suppl","key":"10.1016\/j.ymgme.2023.107583_bb0515","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/S1678-77572009000700012","article-title":"Communicative and psycholinguistic abilities in children with phenylketonuria and congenital hypothyroidism","volume":"17","author":"Gej\u00e3o","year":"2009","journal-title":"J. Appl. Oral. Sci. Rev. FOB"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:53:54Z","timestamp":1761090834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223002135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1096719223002135"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107583","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenylketonuria and the brain","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107583"}}